ANL
Adlai Nortye Ltd. American

32
Mkt Cap
$55.35M
Volume
354.00
52W High
$3.89
52W Low
$1.10
Price
$1.47
ANL Fundamentals
Prev Close
$1.50
Open
$1.54
50D MA
$1.70
Beta
0.00
Avg. Volume
12,368.81
EPS (Annual)
-$1.63
Rev/Employee
$0.00
Loading...
Loading...
Adlai Nortye Ltd. is a clinical-stage biopharmaceutical company, which engages in the provision of development of cancer therapies for patients with stages of tumors. It offers AN0025, a clinical stage, potential EP4 antagonist designed to modulate tumor microenvironment. The company was founded on May 9, 2018, and is headquartered in Hangzhou, China.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
123

Frequently Asked Questions

What is Market Cap of Adlai Nortye Ltd. - ADR?
What is the 52-week high for Adlai Nortye Ltd. - ADR?
What is the 52-week low for Adlai Nortye Ltd. - ADR?
What is Adlai Nortye Ltd. - ADR stock price today?
What was Adlai Nortye Ltd. - ADR stock price yesterday?
What is the 50-day moving average of Adlai Nortye Ltd. - ADR?
How many employess does Adlai Nortye Ltd. - ADR has?

Latest ANL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.